News for DexCom, Inc. (0A4M.L)

Shares of DexCom Inc (DXCM) fell 6.44% in mid-day trading on Mar 10. The stock reached an intraday low of $71.11, before recovering slightly to $72.83, down

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Renée Galá to its Board of Directors, effective March

DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% growth. Learn more on DXCM stock here.

DexCom, Inc. (NASDAQ:DXCM) 46th Annual Raymond James Institutional Investors Conference March 4, 2025 10:25 AM ETCompany ParticipantsJereme Sylvain - Chief...

Shares of DexCom Inc (DXCM) fell 3.67% in mid-day trading on Mar 4. The stock reached an intraday low of $81.77, before recovering slightly to $82.83, down

DexCom Inc (DXCM), a leader in glucose biosensing technology, announced that its management will present an update at the 46th Annual Raymond James Institutiona

[url="]DexCom, Inc.[/url] (NASDAQ:DXCM) today announced that management will present an update on the company at the 46th Annual Raymond James Institutional In

[url="]Tandem Diabetes Care, Inc.[/url] (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation au

PR NewswireBOSTON, Feb. 14, 2025 BOSTON, Feb. 14, 2025 /PRNewswire/ -- Below is the January 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc.

BOSTON, Feb. 14, 2025 /PRNewswire/ -- Below is the January 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG).

Shares of DexCom Inc (DXCM) surged 5.98% in mid-day trading on Feb 14. The stock reached an intraday high of $89.84, before settling at $89.12, up from its

DexCom, Inc. DXCM reported weaker-than-expected earnings for its fourth quarter on Thursday. The company posted quarterly earnings of 45 cents per share which ...

DXCM earnings call for the period ending December 31, 2024.

DexCom, Inc. (NASDAQ:DXCM) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ETCompany ParticipantsSean Christensen - Vice President of Finance and...

The following slide deck was published by DexCom, Inc.

According to a report by Mordor Intelligence, the medical devices market has a size of $681.57 billion as of 2025.

Baron Small Cap Fund declined in the fourth quarter of 2024, trailing its benchmark, the Russell 2000 Growth Index.

DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to find out why I am neutral on DXCM.

We recently compiled a list of the 10 Firms Shine Amid Wall Street's Lackluster Trading. In this article, we are going to take a look at where DexCom, Inc.